Table 1 Socio-demographic characteristics, presented clinical psychiatric disorders and disease duration of SGA-treated and control patients

Age, years, x̃ (range)

10 (8–12)

8.70 (6.9–10.8)

U = 2332

0.056

Gender

X² = 0.024

0.877

 Male, n (%)

 Female, n (%)

41 (56.94)

31(43.06)

44 (55.70)

35(44.30)

Parents education

X² = 1.63

0.20

 Educated, n (%)

 Not educated, n (%)

43 (59.72)

29 (40.28)

39 (49.37)

40 (50.63)

Demographic, n (%)

X² = 0.16

0.69

 Urban

 Rural

47 (65.28)

25 (34.72)

54 (68.35)

25 (31.65)

Psychiatric disorders

 ASD, n (%)

 ADHD, n (%)

 ODD/CD, n (%)

 Schizophreniform, n (%)

20 (27.77)

25 (34.72)

4 (5.56)

4 (5.56)

31 (39.24)

23 (29.11)

5 (6.33)

2 (1.27)

1.88

0.55

1

0.43

0.23

0.46

 > 0.99

0.68

Comorbidity

 ASD-depression, n (%)

 ASD-low IQ, n (%)

 ADHD-low IQ, n (%)

 ADHD-anxiety, n (%)

 CD-substance abuse, n (%)

13 (18.06)

3 (4.17)

5 (6.94)

29 (40.28)

3 (4.17)

9 (11.39)

4 (5.06)

6 (7.59)

27 (34.18)

2 (2.53)

1.34

1

0.89

0.6

0.67

0.25

 > 0.99

 > 0.99

0.44

0.67

 Disease duration, years, x̃ (range)

1.7 (1.3–3.8)

2.1 (1.2–3.1)

U = 2568

0.303

 Disease duration, n (%)

 < 3 years

 > 3 years

56 (77.78)

16 (22.22)

63 (79.75)

16 (20.25)

X² = 0.09

0.77